Safety and Efficacy of the CoolCryo System for Cardiac Cryoablation in the Treatment of Atrial Fibrillation (CoolCryo)
Evaluation of the Safety and Efficacy of the CoolCryo System for Cardiac Cryoablation in the Treatment of Atrial Fibrillation in a Single-arm, Non-randomised, Open-label Clinical Trial
Sponsor: Medinice S.A.
This observational or N/A phase trial investigates Atrial Fibrillation, Paroxysmal or Persistent and Mitral Valve Disease and is currently actively recruiting participants. Medinice S.A. leads this study, which shows 4 recorded versions since 2024 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.
Status Flow
Change History
4 versions recorded-
Oct 2025 — Present [monthly]
Recruiting
-
Mar 2025 — Oct 2025 [monthly]
Recruiting
-
Oct 2024 — Mar 2025 [monthly]
Recruiting
-
Sep 2024 — Oct 2024 [monthly]
Recruiting
First recorded
Jul 2024
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Medinice S.A.
For direct contact, visit the study record on ClinicalTrials.gov .